17 unchanged sentences
Other Information
+Added: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Directors, Executive Officers and Corporate Governance
−Removed: Information required by this Item is incorporated herein by reference to the sections titled “Information about our Executive Officers,” “Election of Class I Directors,” “Corporate Governance Standards and Director Independence” and “Security Ownership of Certain Beneficial Owners and Management” in our Definitive Proxy Statement with respect to our 2021 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
+Added: Information required by this Item is incorporated herein by reference to the sections titled “Information about our Executive Officers,” “Election of Class II Directors,” “Corporate Governance Standards and Director Independence” and “Security Ownership of Certain Beneficial Owners and Management” in our Definitive Proxy Statement with respect to our 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
With regard to the information required by this item regarding compliance with Section 16(a) of the Exchange Act, we will provide disclosure of delinquent Section 16(a) reports, if any, in our Proxy Statement related to the 2022 Annual Meeting of Shareholders, and such disclosure, if any, is incorporated herein by reference.
Executive Compensation
−Removed: Information required by this Item is incorporated herein by reference to the section titled “Executive Compensation,” “Election of Class I Directors,” and “Corporate Governance Standards and Director Independence” in our Definitive Proxy Statement with respect to our 2021 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
+Added: Information required by this Item is incorporated herein by reference to the section titled “Executive Compensation,” “Election of Class II Directors,” and “Corporate Governance Standards and Director Independence” in our Definitive Proxy Statement with respect to our 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
3 unchanged sentences
Principal Accounting Fees and Services
+Added: Our independent registered public accounting firm is KPMG LLP, San Diego, CA, Auditor Firm ID:
Information required by this Item is incorporated herein by reference to the section titled “Ratification of Independent Registered Public Accounting Firm” in our Definitive Proxy Statement with respect to our 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K.
15 unchanged sentences
S-1 333-206849 4.1 December 23, 2015
−Removed: 4.2 Fourth Amended and Restated Investors’ Rights Agreement, dated July 13, 2015, by and among the Registrant and certain of its stockholders.
−Removed: S-1 333-206849 4.2 September 9, 2015
4.2 Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
10 unchanged sentences
10-K 001-37985 10.5 March 5, 2018
−Removed: 10.6 Office Lease, dated April 19, 2011, by and between the Registrant and Kilroy Realty, L.P., as amended.
−Removed: S-1 333-206849 10.8 December 23, 2015
10.6 Antibody Generation Agreement, dated December 22, 2011, by and between the Registrant and Celgene Corporation, as modified.
7 unchanged sentences
S-1 333-206849 10.13 September 9, 2015
−Removed: Incorporated by reference
−Removed: Number Description of Document Form File No.
−Removed: Exhibit Filing
−Removed: 10.11 Amendment No.
−Removed: 1 to Investor Rights.
−Removed: 10-Q 001-37985 4.1 November 8, 2018
10.10 Wateridge Lease Agreement.
2 unchanged sentences
10-Q 001-37985 10.17 November 4, 2020
+Added: Incorporated by reference
+Added: Number Description of Document Form File No.
+Added: Exhibit Filing
Employment Agreement, effective July 15, 2020, by and between Registrant and Dennis Mulroy
4 unchanged sentences
3 to the Collaboration and Exclusive License Agreement
+Added: 10-K 001-37985 10.16 February 25, 2021
10.15 Termination of Sublease
+Added: 10-K 001-37985 10.17 February 25, 2021
Confidential Settlement and Modification Agreement dated as of October 23, 2020
+Added: 10-K 001-37985 10.18 February 25, 2021
+Added: 10.17 First Amendment to Lease Agreement
+Added: 10-Q 001-37985 10.19 August 9, 2021
+Added: Royalty Purchase Agreement, dated October 25, 2021, by and between the Registrant and Sagard Healthcare Royalty Partners, LP
+Added: 8-K 001-37985 2.1 December 1, 2021
+Added: 10.19 Amendment No.
+Added: 4 to Tesaro AnaptysBio Collaboration
21.1 Subsidiaries of the Registrant.
17 unchanged sentences
+ Registrant has omitted and filed separately with the SEC portions of the exhibit pursuant to a confidential treatment request under Rule 406 promulgated under the Securities Act.
+Added: ++ Certain portions of this exhibit have been omitted by means of marking such portions with asterisks because the Registrant has determined that the information is not material and is the type that the Registrant treats as private or confidential.
+Added: ‡ Exhibits and schedules to this agreement have been omitted pursuant to the rules of the SEC.
+Added: The Registrant will submit copies of such exhibits and schedules to the SEC upon request.
Form 10-K Summary
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized .
−Removed: February 25, 2021
+Added: March 7, 2022
AnaptysBio, Inc.
6 unchanged sentences
/s/ Hamza Suria President, Chief Executive Officer and Director
−Removed: Hamza Suria (Principal Executive Officer) February 25, 2021
+Added: Hamza Suria (Principal Executive Officer) March 7, 2022
/s/ Dennis Mulroy Chief Financial Officer
−Removed: Dennis Mulroy (Principal Accounting and Financial Officer) February 25, 2021
−Removed: /s/ Dennis Fenton Director February 25, 2021
+Added: Dennis Mulroy (Principal Accounting and Financial Officer) March 7, 2022
+Added: /s/ Daniel Faga Director March 7, 2022
+Added: /s/ Dennis Fenton Director March 7, 2022
Dennis Fenton, Ph.D.
−Removed: Hamill Director February 25, 2021
−Removed: /s/ Magda Marquet Director February 25, 2021
+Added: Hamill Director March 7, 2022
+Added: /s/ Magda Marquet Director March 7, 2022
Magda Marquet, Ph.D.
−Removed: /s/ Hollings Renton Director February 25, 2021
+Added: /s/ Oleg Nodelman Director March 7, 2022
+Added: Oleg Nodelman
+Added: /s/ Hollings Renton Director March 7, 2022
Hollings Renton
−Removed: /s/ John Schmid Director February 25, 2021
−Removed: Topper Director February 25, 2021
+Added: /s/ John Schmid Director March 7, 2022
+Added: Topper Director March 7, 2022
Topper, M.D., Ph.D.
−Removed: Anthony Ware Director February 25, 2021
+Added: Anthony Ware Director March 7, 2022
Anthony Ware, M.D.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.